Investor Alert

New York Markets After Hours

Coronavirus Update Archives | Email alerts

Jan. 7, 2021, 2:40 p.m. EST

U.S. counts record of almost 4,000 COVID-19 deaths in a day as virus continues to wreak havoc

Experts fear the mob that stormed the U.S. Capitol on Wednesday may have created a superspreader event as few wore face masks

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Johnson & Johnson (JNJ)
  • X
    Dow Jones Industrial Average (DJIA)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Ciara Linnane, MarketWatch

Getty Images
Many of the crowd that stormed the U.S. Capital on Wednesday did not wear a face mask

As the political drama unfolded in Washington, D.C. on Wednesday, COVID-19 continued to wreak havoc in the U.S., claiming a record of almost 4,000 American lives, the most in a single day since the start of the outbreak.

There were at least 3,963 COVID-19 deaths, according to a New York Times tracker, and another 255,730 cases were diagnosed. The U.S. has averaged 230,610 cases a day for the past week, numbers that are higher than the worst case scenarios envisaged by experts early in the crisis.

There were a record of 132,476 COVID-19 patients in U.S. hospitals, according to the COVID Tracking Project, beating the record of 131,215 set a day ago.

Several states, including New Hampshire, Oklahoma and Pennsylvania, set single-day records for deaths, and Illinois joined four other states — California, New York, Florida and Texas — which have reported more than a million cases.

The U.S. continues to lead the world by cases, at 21.4 million, and deaths, at 362,828, according to data aggregated by Johns Hopkins University, or about a fifth of the global totals. The U.S. has more than double the number of cases as India, at 10.3 million, the second highest tally in the world.

The mob that stormed the U.S. Capitol building likely created a superspreader event during and after the event also, as few wore face masks, according to experts. Such superspreader events are expected to increase given the highly infectious new variant of the virus that first emerged in the U.K. and is deemed to be 40% to 70% more transmissible than the original virus.

Rep. Susan Wild, a Pennsylvania Democrat, told CBS that members of Congress who were placed in a secure location during the riot with 300 people to 400 people, also created a superspreader event as many lawmakers refused to wear a face mask.

“It’s what I would call a COVID super spreader event. About half of the people in the room are not wearing masks, even though they’ve been offered surgical masks,” Wild said on CBS. “They’ve refused to wear them.”

Wild said Republicans were the main refuseniks, with some freshman Republican congressmen “openly flaunting” the fact that they would not wear a mask.

“It’s exactly the kind of situation that we’ve been told by the medical doctors not to be in, you know, close proximity, especially with people who aren’t wearing masks,” Wild added. “We weren’t even allowed to get together with our families for Thanksgiving and Christmas, and now we’re in a room with people who are flaunting the rules and are very much crowded in here.”

Meanwhile, the U.S. vaccination program continues to make painfully slow progress. The Centers for Disease Control and Prevention’s vaccine tracker shows that as of 9.00 a.m. ET Wednesday, just 5.3 million people had been dosed, and 17.3 million doses distributed, far below the most recently revised promise of 20 million by end-December. The federal government had originally promised 100 million doses would be delivered in that time frame.

President Donald Trump has left it to states to administer the vaccine program — tweeting that it was “up to the states to administer” and then calling some states “very slow” — meaning that stressed state health departments, which have already had to deal with testing, contact tracing, public information campaigns and deciding when or whether schools or businesses should be open or closed, are now tasked with handling the biggest public health effort in decades.

See: January will be worst month for U.S. pandemic so far with post-holiday travel cases seen surging

Dr. Nancy Messonnier, director of the CDC’s National Center for Immunization and Respiratory Diseases, said Wednesday that part of the delay is due to the fact that the vaccine program was launched during a holiday week.

“I think because of that, many jurisdictions had planned for slightly measured initial weeks of rollout to get them comfortable with the vaccine and, again, to account for it being the holiday week. Now that the holidays over I except this program to continue to escalate and actually escalate really quickly,” she told reporters on a call.

See now: CDC officials say people with history of allergic reactions should be monitored after receiving a COVID-19 shot

“I continue to believe that the risk of COVID and the risk of poor outcomes, especially in senior citizens, makes it imperative that people go ahead and get vaccinated as soon as it’s available to them,” she said.

In other news:

• A new report suggests the U.S.’ high numbers are vastly understated. The cross-sectional study, which was published Tuesday in JAMA Network Open , examined under-reporting for infections, hospitalizations and deaths related to COVID-19 in the U.S., estimating that there were roughly 46 million cases, including 28 million symptomatic infections; about 950,000 hospitalizations; and 305,000 deaths through Nov. 15. The researchers say case counts, hospitalizations, and deaths are likely much higher because many people with symptomatic infections as well as most asymptomatic people did not seek medical care and were not tracked in the health system. “There remains a substantial gap between the estimated proportion of the population infected and the proportion infected that is required for herd immunity,” which is thought to be around 60%, the researchers concluded.

• The COVID-19 vaccine candidate being developed by Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.20% subsidiary Janssen Pharmaceutica could be granted emergency authorization by U.K. regulators within weeks, boosting the country’s mass immunization program amid a surge of coronavirus cases, MarketWatch’s Lina Saigol reported. John Bell, regius professor of medicine at the University of Oxford and an adviser to the U.K.’s Vaccine Taskforce, told the Daily Telegraph: “My prediction is that it’ll work well, although we need to wait for the trial results.” He added: “I think they will have supplies available for the U.K. in a time frame that would allow it just to catch the mid-February target of getting the numbers up. I think it may well have a material impact on what we can do in the U.K. to get more people vaccinated.”

• The World Health Organization’s regional head for Europe Hans Kluge is warning that more needs to be done to deal with the new variant of the virus that is racing across the continent. Kluge told reporters at a briefing that the new strain is “a tipping point” in the course of the pandemic. “This is an alarming situation, which means that for a short period of time we need to do more than we have done and to intensify the public health and social measures to be certain we can flatten the steep vertical line in some countries,” Kluge said.

• Russia passed a grim milestone on Thursday of more than 60,000 deaths from COVID-19, The Moscow Times reported. Official figures showed 506 new deaths and 23,541 new cases in the past 24 hours. Russia has had 3.3 million confirmed cases of the deadly illness and 60,457 people have died.

$ 163.72
+0.32 +0.20%
Volume: 4.30M
Oct. 22, 2021 4:00p
P/E Ratio
Dividend Yield
Market Cap
$430.15 billion
Rev. per Employee
1 2
This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.